Status | Study |
Active, not recruiting |
Study Name: Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Condition: Adult Brain Tumor Adult Brain Stem Glioma Adult Diffuse As Date: 2009-12-02 Interventions: Radiation: proton beam radiation therapy |
Completed |
Study Name: Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma Condition: Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Date: 2008-07-19 Interventions: Biological: Cixutumumab Given |
Completed |
Study Name: Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma Condition: CNS Cancer Meningioma Intracranial H Date: 2007-12-26 Interventions: Drug: Sunitinib The study drug will be administered on an outpatient basis. The starting dose will be 50 |
Completed |
Study Name: Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck Cancer Condition: Adult Anaplastic Astrocytoma Adult Anaplastic Ependymoma A Date: 2007-06-25 Interventions: Drug: bevacizumab Given IV |
Active, not recruiting |
Study Name: Trial of Dasatinib in Advanced Sarcomas Condition: Rhabdomyosarcoma Malignant Peripheral Nerve Sheath Tumors Date: 2007-04-20 Interventions: Drug: Dasatinib oral agent, continuous dosing, Cycles = 28 days |
Completed |
Study Name: Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery Condition: Childhood Malignant Fibrous Histiocytoma of Bone Sarcoma Date: 2007-03-20 Interventions: Drug: celecoxib Procedure: adjuvant therap |
Completed |
Study Name: Vatalanib in Treating Patients With Recurrent or Progressive Meningioma Condition: Brain and Central Nervous System Tumors Sarcoma Date: 2006-07-05 Interventions: Drug: vatalanib Other Names: PTK787 ZK 222584 |
Completed |
Study Name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma Condition: Adult Alveolar Soft-part Sarcoma Adult Angiosarcoma Adult Date: 2006-06-28 Interventions: Drug: doxorubicin hydrochloride |
Completed |
Study Name: S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas Condition: Sarcoma Date: 2005-09-20 Interventions: Drug: sorafenib 800 mg per day, daily until progression |
Completed |
Study Name: Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases Condition: Life Threatening Diseases Date: 2005-09-09 Interventions: Drug: Imatinib mesylate |